Pricing Log in Create free account

CASI Pharmaceuticals Inc. (CASIF) vs Fractyl Health, Inc. (GUTS)

CASI Pharmaceuticals Inc. and Fractyl Health, Inc. are both Biotechnology companies. CASI Pharmaceuticals Inc. and Fractyl Health, Inc. are of similar size ($12.4M and $11.9M). Fractyl Health, Inc. grew revenue faster over the last twelve months: −22.5% against −27.4%. Fractyl Health, Inc. has the higher net margin (0.00% vs −232.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Fractyl Health, Inc. leads on 10 and CASI Pharmaceuticals Inc. on 5.

Valuation

Metric CASIF GUTS Biotechnology median
P/E n/m n/m 10.26
P/S 0.09 127.89 9.18
P/B n/m n/m 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.06 0.65
EV/Sales 1.79 (51.61) 8.98
Earnings yield (2,701.50%) (1,173.80%) (34.89%)
Free cash flow yield (3,801.00%) (697.71%) (24.52%)

Profitability

Metric CASIF GUTS Biotechnology median
Gross margin 48.65% 46.24% 65.16%
Operating margin (206.87%) 0.00% 0.00%
Net margin (232.03%) 0.00% 0.00%
Free cash flow margin (340.20%) 0.00% 0.00%
Return on equity 0.00% 1,063.04% (50.12%)
Return on assets 0.00% (146.75%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CASIF GUTS Biotechnology median
Revenue growth (TTM) (27.42%) (22.50%) 6.26%
EPS growth (last fiscal year) (1.17%) (14.81%) 29.88%
Revenue growth, 5-year CAGR 6.47% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CASIF GUTS Biotechnology median
Debt to equity (0.34) (18.29) 0.00
Current ratio 0.15 3.15 4.89
Net debt to EBITDA (0.43) 0.53 1.01

Dividend

Metric CASIF GUTS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CASIF GUTS Biotechnology median
Market cap 12.39m 11.88m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack